JERUSALEM, February 16, 2022 / PRNewswire / – Alpha Tau Medical is pleased to announce that its innovative alpha-radiation cancer therapy – Alpha DaRT ™ has been awarded the Innovation Quality Award in 2021 in the category health innovationas well as in the overall innovation quality competition as “Innovation Innovation” from Laautekeskus Excellence Finland.
A total of 561 innovations in five separate categories from 18 different countries took part in the competition. Only the top 25 innovations were awarded prizes or prizes.
The winners of the award were evaluated on 5 different criteria: their value of novelty, ease of use, use of training, meeting the unmet needs of customers and efficiency in solving current problems. Judges considered Alpha DaRT the most successful in the novelty of using alpha radiation to treat many types of cancer, its potential to meet the unmet needs of patients with late-stage and radiation-resistant cancer, and to achieve recognition through extensive clinical trials. treatment evaluation program. They presented Alpha DaRT with a double award health innovation and the top prize of the overall innovation competition “Innovation is innovationThe award will be presented by the President of the Republic Finland.
CEO of Alpha Tau, Uzi Sofercommented: “We are very pleased that our hard work in developing Alpha DaRT technology has been rewarded as a supreme innovation. We will continue to accelerate the way to make our treatments available to cancer patients, with a focus on those with multiple available treatment options, in those who have had recurrences of the disease, and in those who have metastatic systemic spread ”.
Chief Technology Officer Alpha Tau Ronen Seagal added: “Alpha DaRT promises to present new treatment options for patients with categories of high unmet need, such as recurrent, metastatic and locally advanced cancer. We are pleased with this recognition from our colleagues.”
For more information, visit www.laatukeskus.fi or www.qualityinnovation.org or contact Juha Julia-Autia, Chair of the 2021 Quality Innovation Award from Laatukeskus Excellence Finland.
+358 40 752 3312
About Alpha DaRT
Alpha DaRT (Diffusing Alpha-Emitter Radiation Therapy) is designed to enable very strong and conformal alpha irradiation of solid tumors by intra-tumor delivery of sources impregnated with radium-224. When radium breaks down, its short-lived daughters are released from the source and disperse, releasing high-energy alpha particles to destroy the tumor. Because alpha-emitting atoms diffuse only a short distance, Alpha DaRT is aimed at affecting mainly the tumor and maintaining healthy tissue around it.
About Alpha Tau Medical Ltd.
Founded in 2016, Alpha Tau is an Israeli medical device company focused on research, development and potential commercialization of Alpha DaRT for the treatment of solid tumors. The technology was originally developed by prof. Yitzhak Kelson and prof. Jonah Caesar from Tel Aviv University.
Contact: Amnon Gath
SOURCE Alpha Tau Medical